As the treatment progresses and the dosage increases, the appetite-suppressing effects become stronger and more consistent
Some patients front-load for a few weeks if they're starting from low levels
Among patients with pre-existing substance use disorder, GLP-1s were tied to fewer hospitalizations, overdoses and deaths related to substance use
A randomised clinical trial demonstrated that colonic infusion of SCFA mixtures, including butyrate, increased fat oxidation and raised fasting and postprandial plasma PYY concentrations in overweight and obese individuals [3]
They can review factors such as your personal and family health history, current weight, and health conditions to determine if GLP-1 therapy is suitable for you
Your provider may adjust dosing over time to support consistent and comfortable progress